WHO COOPERATIVE TRIAL ON PRIMARY PREVENTION OF ISCHAEMIC HEART DISEASE WITH CLOFIBRATE TO LOWER SERUM CHOLESTEROL: FINAL MORTALITY FOLLOW-UP. Report of the Committee of Principal Investigators

The Lancet

Volumn 324, Issue 8403, 1984, Pages 600-604

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CLOFIBRATE;

ANGINA PECTORIS; BLOOD AND HEMOPOIETIC SYSTEM; CHOLESTEROL BLOOD LEVEL; DRUG THERAPY; EPIDEMIOLOGY; HEART; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR SYSTEM; PREVENTION; PRIMARY PREVENTION; THERAPY;

CHOLESTEROL; CLINICAL TRIALS; CLOFIBRATE; CORONARY DISEASE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASMS;

EID: 84920245150     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(84)90595-6     Document Type: Article

References (4)

1. A cooperative trial in the prevention of ischaemic heart disease using clofibrate
2. WHO cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up
3. A cooperative trial on the primary prevention of ischaemic heart disease using clofibrate: Design, methods and progress
4. Postmarketing surveillance of adverse drug reactions in general practice